Loading...
Bausch Health Companies Inc.
BHC•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$6.83
$0.07(1.03%)
Bausch Health Companies Inc. (BHC) Financial Performance & Income Statement Overview
Review Bausch Health Companies Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.69%
↑ 8.69%
Operating Income Growth
60.54%
↑ 60.54%
Net Income Growth
92.60%
↑ 92.60%
Operating Cash Flow Growth
54.75%
↑ 54.75%
Operating Margin
16.43%
↑ 16.43%
Gross Margin
64.65%
↑ 64.65%
Net Profit Margin
-0.44%
↓ 0.44%
ROE
4.70%
↑ 4.70%
ROIC
5.97%
↑ 5.97%
Bausch Health Companies Inc. (BHC) Income Statement & Financial Overview
Review Bausch Health Companies Inc.'s (BHC) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.23B | $2.46B | $2.51B | $2.40B |
| Cost of Revenue | $701.00M | $727.00M | $977.80M | $988.80M |
| Gross Profit | $1.53B | $1.74B | $1.53B | $1.41B |
| Gross Profit Ratio | $0.69 | $0.70 | $0.61 | $0.59 |
| R&D Expenses | $143.00M | $158.40M | $161.00M | $155.97M |
| SG&A Expenses | $867.00M | $820.00M | $850.00M | $831.83M |
| Operating Expenses | $1.28B | $1.27B | $996.00M | $987.80M |
| Total Costs & Expenses | $1.98B | $2.001B | $1.98B | $1.98B |
| Interest Income | $11.00M | $9.00M | $7.00M | $8.00M |
| Interest Expense | $330.00M | $337.00M | $346.00M | $350.00M |
| Depreciation & Amortization | -$7.00M | $298.34M | $324.59M | $317.93M |
| EBITDA | $276.00M | $853.00M | $647.00M | $718.85M |
| EBITDA Ratio | $0.12 | $0.35 | $0.26 | $0.30 |
| Operating Income | $276.00M | $558.00M | $318.00M | $425.91M |
| Operating Income Ratio | $0.12 | $0.23 | $0.13 | $0.18 |
| Other Income/Expenses (Net) | -$323.00M | -$349.00M | -$339.00M | -$341.00M |
| Income Before Tax | -$47.00M | $209.00M | -$21.00M | $47.99M |
| Income Before Tax Ratio | -$0.02 | $0.08 | -$0.008 | $0.02 |
| Income Tax Expense | $39.00M | $107.87M | $71.57M | $48.99M |
| Net Income | -$58.00M | $90.38M | -$85.00M | $10.00M |
| Net Income Ratio | -$0.03 | $0.04 | -$0.03 | $0.004 |
| EPS | -$0.16 | $0.25 | -$0.23 | $0.03 |
| Diluted EPS | -$0.16 | $0.25 | -$0.23 | $0.03 |
| Weighted Avg Shares Outstanding | $362.50M | $367.80M | $368.40M | $367.90M |
| Weighted Avg Shares Outstanding (Diluted) | $362.50M | $367.80M | $368.40M | $370.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan